Quo-Lab meets strict international quality targets – confirming it fit for purpose for diabetes testing The study aimed to evaluate the four POC HbA1c instruments according to Clinical and Laboratory ...
EKF Diagnostics has announced that its Quo-Lab HbA1c point-of-care analyzer has successfully achieved International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) certification. The ...
New research shows that the diabetes/obesity medication tirzepatide can cause clinically meaningful improvements in blood sugar control and weight loss in children and adolescents with type 2 diabetes ...
EKF Diagnostics has announced that in a newly published paper [1] its Quo-Test® point-of-care (POC) hemoglobin A1c (HbA1c) analyzer has again been confirmed to meet International Federation of ...
Hemoglobin A1c (HbA1c) remains the predominant analyte for the diagnosis and monitoring of diabetes mellitus worldwide.
DUBLIN, IRELAND--(Marketwired - Aug 8, 2014) - Research and Markets (http://www.researchandmarkets.com/research/vfzzkh/hemoglobin_a1c) has announced the addition of ...
Dublin, March 16, 2023 (GLOBE NEWSWIRE) -- The "Hemoglobin A1C (HbA1C) Testing: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for ...
Nearly half of U.S. adults say starting a new diet is one of their New Year's resolutions, according to a new Physicians Committee for Responsible Medicine/Morning Consult survey. More than 80% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results